Strategies to prevent hypertrophic scar formation: a review of therapeutic interventions based on molecular evidence

被引:125
作者
Shirakami, Eri [1 ]
Yamakawa, Sho [1 ]
Hayashida, Kenji [1 ]
机构
[1] Shimane Univ, Div Plast & Reconstruct Surg, Fac Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan
关键词
Hypertrophic scar; Therapy; Intervention; Cytokines; TOXIN TYPE-A; RANDOMIZED CONTROLLED-TRIAL; ENDOTHELIAL GROWTH-FACTOR; RABBIT EAR MODEL; BOTULINUM TOXIN; DOUBLE-BLIND; BURN; KELOIDS; OXANDROLONE; LASER;
D O I
10.1093/burnst/tkz003
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
Once scar tissues mature, it is impossible for the surrounding tissue to regenerate normal dermal tissue. Therefore, it is essential to understand the fundamental mechanisms and establish effective strategies to inhibit aberrant scar formation. Hypertrophic scar formation is considered a result of the imbalance between extracellular matrix synthesis and degradation during wound healing. However, the underlying mechanisms of hypertrophic scar development are poorly understood. The purpose of this review was to outline the management in the early stage after wound healing to prevent hypertrophic scar formation, focusing on strategies excluding therapeutic agents of internal use. Treatment aimed at molecular targets, including cytokines, will be future options to prevent and treat hypertrophic scars. More basic studies and clinical trials, including combination therapy, are required to investigate the mechanisms and prevent hypertrophic scar formation.
引用
收藏
页数:8
相关论文
共 94 条
[1]
Oxandrolone protects against the development of multiorgan failure, modulates the systemic inflammatory response and promotes wound healing during burn injury [J].
Ahmad, Akbar ;
Herndon, David N. ;
Szabo, Csaba .
BURNS, 2019, 45 (03) :671-681
[2]
Pulsed dye laser treatment of hypertrophic burn scars [J].
Alster, TS ;
Nanni, CA .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1998, 102 (06) :2190-2195
[3]
Vascularization pattern in hypertrophic scars and keloids:: A stereological analysis [J].
Amadeu, T ;
Braune, A ;
Mandarim-de-Lacerda, C ;
Porto, LC ;
Desmoulière, A ;
Costa, A .
PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (07) :469-473
[4]
CHARACTERIZATION OF COLLAGEN OF HUMAN HYPERTROPHIC AND NORMAL SCARS [J].
BAILEY, AJ ;
BAZIN, S ;
SIMS, TJ ;
LELOUS, M ;
NICOLETIS, C ;
DELAUNAY, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1975, 405 (02) :412-421
[5]
Intralesional Injection of Botulinum Toxin Type A Compared with Intralesional Injection of Corticosteroid for the Treatment of Hypertrophic Scar and Keloid: A Systematic Review and Meta-Analysis [J].
Bi, Minglei ;
Sun, Pengfei ;
Li, Danyi ;
Dong, Zheng ;
Chen, Zhenyu .
MEDICAL SCIENCE MONITOR, 2019, 25 :2950-2958
[6]
Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation [J].
Bi, Xiuli ;
Tong, Chang ;
Dockendorff, Ashley ;
Bancroft, Laura ;
Gallagher, Lindsay ;
Guzman, Grace ;
Iozzo, Renato V. ;
Augenlicht, Leonard H. ;
Yang, Wancai .
CARCINOGENESIS, 2008, 29 (07) :1435-1440
[7]
Prevention and curative management of hypertrophic scar formation [J].
Bloemen, Monica C. T. ;
van der Veer, Willem M. ;
Ulrich, Magda M. W. ;
van Zuijlen, Paul P. M. ;
Niessen, Frank B. ;
Middelkoop, Esther .
BURNS, 2009, 35 (04) :463-475
[8]
Prevention or treatment of hypertrophic burn scarring: A review of when and how to treat with the Pulsed Dye Laser [J].
Brewin, M. P. ;
Lister, T. S. .
BURNS, 2014, 40 (05) :797-804
[9]
EXPRESSION OF VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) BY EPIDERMAL-KERATINOCYTES DURING WOUND-HEALING [J].
BROWN, LF ;
YEO, KT ;
BERSE, B ;
YEO, TK ;
SENGER, DR ;
DVORAK, HF ;
VANDEWATER, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1375-1379
[10]
Burn Scar Lipofilling: Immunohistochemical and Clinical Outcomes [J].
Bruno, Agostino ;
Santi, Giancarlo Delli ;
Fasciani, Lucio ;
Cempanari, Michela ;
Palombo, Marco ;
Palombo, Paolo .
JOURNAL OF CRANIOFACIAL SURGERY, 2013, 24 (05) :1806-1814